CLINICAL DRUG SUBSTANCE SUPPLY AGREEMENTClinical Drug Substance Supply Agreement • December 4th, 2008 • Facet Biotech Corp • Pharmaceutical preparations • New York
Contract Type FiledDecember 4th, 2008 Company Industry JurisdictionTHIS CLINICAL DRUG SUBSTANCE SUPPLY AGREEMENT (this “Agreement”) is effective as of the Effective Date (as defined below) and is by and between GMN, Inc., a Delaware corporation and a wholly owned subsidiary of Genmab A/S, a corporation organized under the laws of Denmark, having its principal place of business at 9450 Winnetka Avenue N, Brooklyn Park, MN (“GMN”) and PDL BioPharma, Inc., a corporation organized under the laws of Delaware, having its principal place of business at 1400 Seaport Boulevard, Redwood City, CA 94063 (“PDL”).
CLINICAL DRUG SUBSTANCE SUPPLY AGREEMENTClinical Drug Substance Supply Agreement • October 27th, 2008 • Facet Biotech Corp • Pharmaceutical preparations • New York
Contract Type FiledOctober 27th, 2008 Company Industry JurisdictionTHIS CLINICAL DRUG SUBSTANCE SUPPLY AGREEMENT (this “Agreement”) is effective as of the Effective Date (as defined below) and is by and between GMN, Inc., a Delaware corporation and a wholly owned subsidiary of Genmab A/S, a corporation organized under the laws of Denmark, having its principal place of business at 9450 Winnetka Avenue N, Brooklyn Park, MN (“GMN”) and PDL BioPharma, Inc., a corporation organized under the laws of Delaware, having its principal place of business at 1400 Seaport Boulevard, Redwood City, CA 94063 (“PDL”).